Somerset, N.J.-based Gavis Pharmaceuticals — a subsidiary of Mumbai-based Lupin Limited — recently earned approval from the Food and Drug Administration for its hydrocodone bitartrate and acetaminophen tablets.
The tablets are intended to relieve moderate to moderately severe pain.
The FDA approved the painkiller as a generic equivalent of Mikart’s hydrocodone bitartrate and acetaminophen tablets.
FDA adds box warning to birth control device Essure
Fire in Amazon distribution center forces some retailers to pull products off website
Novartis considers selling eye division
Presenters: Joel Ray, COL, USAF, NC, MSN, RN, NEA-BC, Laudio and StaffGarden by Ascend LearningLarissa Africa, MBA, RN, CENP, FAONL, FAAN, StaffGarden by Ascend LearningAlicia Potolsky, DNP, RN, NE-BC, DipACLM, El Camino HealthJulie Balluck, DNP, RN, NEA-BC, Texas Health Resources
Comments are closed.
